{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:12Z","timestamp":1790700132916,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neurosyphilis does not necessarily involve progressive invasion from interstitial to parenchymal nerve tissue. Few studies have focused on human immunodeficiency virus (HIV)-negative patients with symptomatic neurosyphilis, and the clinical outcomes and factors influencing the outcomes are unclear. Therefore, in this study, we aimed to compare the characteristics and clinical outcomes of interstitial and parenchymal neurosyphilis following treatment in HIV-negative patients with symptomatic neurosyphilis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of the clinical characteristics, laboratory results, neuroimaging findings, treatment regimens, and outcomes at discharge of HIV-negative patients admitted to our hospital with symptomatic neurosyphilis between May 2013 and May 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 142 patients, the mean age was 56.6\u202f\u00b1\u202f11.4\u202fyears, with 111 (78.2%) being men. The predominant clinical manifestations included psychological disorders, cognitive decline, and cranial nerve disorders. Overall, 134 (94.4%) patients had elevated cerebrospinal fluid (CSF) cell counts, 113 (79.6%) had elevated protein levels, and 22\/133 (16.5%) had elevated intracranial pressure. During hospitalization 113 patients (87.6%) were treated with intravenous penicillin and 13 (10.1%) were treated with ceftriaxone. Furthermore, 62 (43.7%) and 80 (56.3%) patients had interstitial and parenchymal types of neurosyphilis, respectively. Patients with the parenchymal type were younger and had higher platelet-to-lymphocyte ratio (PLR) and lower lymphocyte-to-monocyte ratio (LMR). Overall, 126 (88.7%) patients completed anti-syphilitic treatment prior to discharge, with 111 (88.1%) showing poor outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>An elevated CSF protein level and the parenchymal type were associated with poor outcome. This study revealed that clinical manifestations of neurosyphilis vary, and that the majority of patients had elevated CSF cell and protein levels and a normal intracranial pressure. The PLR was higher and the LMR was lower in the parenchymal type than in the interstitial type. Only a small proportion of patients had favorable outcomes. CSF protein level and parenchymal type may be risk factors for poor prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1505818","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T02:32:45Z","timestamp":1738722765000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Symptomatic neurosyphilis in HIV-negative patients: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Qiaoer","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000347109","article-title":"Clinical spectrum of neurosyphilis among HIV-negative patients in the modern era","volume":"226","author":"Zhang","year":"2013","journal-title":"Dermatology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1001\/jama.290.11.1510","article-title":"Update on syphilis: resurgence of an old problem","volume":"290","author":"Golden","year":"2003","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1906228","article-title":"Neurosyphilis","volume":"381","author":"Ropper","year":"2019","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s10072-023-07285-8","article-title":"Enhancing clinical awareness: retrospective analysis of neurosyphilis cases and diagnostic predictors for early recognition and treatment","volume":"45","author":"Gao","year":"2024","journal-title":"Neurol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2426313","article-title":"Clinical and laboratory characteristics of symptomatic and asymptomatic neurosyphilis in HIV-negative patients: a retrospective study of 264 cases","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed Res Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.jiac.2021.07.004","article-title":"Clinical, laboratory and brain magnetic resonance imaging (MRI) characteristics of asymptomatic and symptomatic HIV-negative neurosyphilis patients","volume":"27","author":"He","year":"2021","journal-title":"J Infect Chemother"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10072-009-0134-7","article-title":"Neurosyphilis in the age of AIDS: clinical and laboratory features","volume":"30","author":"Gita\u00ed","year":"2009","journal-title":"Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/cid\/ciaa1714","article-title":"Neurosyphilis treatment outcomes after intravenous penicillin G versus intramuscular procaine penicillin plus oral probenecid","volume":"71","author":"Dunaway","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.micpath.2019.03.008","article-title":"Changes of T lymphocyte subsets in patients with HIV-negative symptomatic neurosyphilis","volume":"130","author":"Liu","year":"2019","journal-title":"Microb Pathog"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12879-017-2339-3","article-title":"Novel predictors of neurosyphilis among HIV-negative syphilis patients with neurological symptoms: an observational study","volume":"17","author":"Xiao","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10096-017-2973-0","article-title":"The burden and epidemiology of community-acquired central nervous system infections: a multinational study","volume":"36","author":"Erdem","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"CD011399","DOI":"10.1002\/14651858.CD011399.pub2","article-title":"Antibiotic therapy for adults with neurosyphilis","volume":"2019","author":"Buitrago-Garcia","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/s1473-3099(20)30857-4","article-title":"Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study","volume":"21","author":"Bettuzzi","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jinf.2023.03.019","article-title":"Neurosyphilis among people with and without HIV infection: a Danish nationwide prospective, population-based cohort study 2015\u20132021","volume":"86","author":"Schnohr","year":"2023","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.35541\/cjd.20190808","article-title":"Guidelines for diagnosis and treatment of syphilis, gonorrhea and genital Chlamydia trachomatis infection","volume":"53","author":"Wang","year":"2020","journal-title":"Chin J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/eip.12441","article-title":"Medial temporal lobe atrophy as a predictor of poor cognitive outcomes in general paresis","volume":"13","author":"Chen","year":"2019","journal-title":"Early Interv Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s10096-021-04253-y","article-title":"Neurosyphilis: a series of 178 cases at the 3rd-level hospital of Marrakesh (Morocco)","volume":"40","author":"Kissani","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10096-018-3403-7","article-title":"Predictors of unfavorable outcome in neurosyphilis: multicenter ID-IRI study","volume":"38","author":"Ozturk-Engin","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.33588\/rn.6902.2018381","article-title":"Clinical and socio-demographic profile of neurosyphilis: a retrospective study in a reference centre in Colombia","volume":"69","author":"Quintero-Moreno","year":"2019","journal-title":"Rev Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0238617","DOI":"10.1371\/journal.pone.0238617","article-title":"Neurosyphilis: still prevalent and overlooked in an at risk population","volume":"15","author":"Ramachandran","year":"2020","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/imj.15691","article-title":"Neurosyphilis in the Northern Territory of Australia: a clinical guideline","volume":"53","author":"Birrell","year":"2023","journal-title":"Intern Med J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/etm.2021.9616","article-title":"Combination of the neutrophil to lymphocyte ratio and serum toluidine red unheated serum test titer as a predictor of neurosyphilis in HIV-negative patients","volume":"21","author":"He","year":"2021","journal-title":"Exp Ther Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/imr.12671","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese","year":"2018","journal-title":"Immunol Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/1708538114522227","article-title":"The relationship between complete blood count parameters and Fontaine's stages in patients with peripheral arterial disease","volume":"22","author":"Demirtas","year":"2014","journal-title":"Vascular"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis, and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: bridging inflammation and cardiovascular disease","volume":"100","author":"von Hundelshausen","year":"2007","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bjid.2014.10.008","article-title":"Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosis","volume":"19","author":"Wang","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e01429","DOI":"10.1002\/brb3.1429","article-title":"Monocyte\/lymphocyte ratio is associated with carotid stenosis in ischemic stroke: a retrospective analysis","volume":"9","author":"Zuo","year":"2019","journal-title":"Brain Behav"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3109\/09537104.2014.979340","article-title":"The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events","volume":"26","author":"Balta","year":"2015","journal-title":"Platelets"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3390\/healthcare10122578","article-title":"The analysis of blood inflammation markers as prognostic factors in Parkinson\u2019s disease","volume":"10","author":"Stanca","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.3748\/wjg.v26.i31.4639","article-title":"Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients","volume":"26","author":"Jakubowska","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12957-020-01962-0","article-title":"Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients","volume":"18","author":"Lin","year":"2020","journal-title":"World J Surg Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1177\/0300060519860686","article-title":"Diagnostic value of the blood monocyte-lymphocyte ratio in knee osteoarthritis","volume":"47","author":"Gao","year":"2019","journal-title":"J Int Med Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e101119","DOI":"10.1371\/journal.pone.0101119","article-title":"Prognostic value of PLR in various cancers: a meta-analysis","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1505818\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T02:32:48Z","timestamp":1738722768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1505818\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":37,"alternative-id":["10.3389\/fpubh.2025.1505818"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1505818","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"1505818"}}